Literature DB >> 7054710

Successful treatment of primary amebic meningoencephalitis.

J S Seidel, P Harmatz, G S Visvesvara, A Cohen, J Edwards, J Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7054710     DOI： 10.1056/NEJM198202113060607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  52 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis.

Authors:  W Matthew Linam; Mubbasheer Ahmed; Jennifer R Cope; Craig Chu; Govinda S Visvesvara; Alexandre J da Silva; Yvonne Qvarnstrom; Jerril Green
Journal:  Pediatrics       Date:  2015-02-09       Impact factor: 7.124

3.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

4.  Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae.

Authors:  F L Schuster; N Mandel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 5.  Naegleria fowleri: pathogenesis, diagnosis, and treatment options.

Authors:  Eddie Grace; Scott Asbill; Kris Virga
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

6.  Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum.

Authors:  M F Reilly; F Marciano-Cabral; D W Bradley; S G Bradley
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

7.  Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri.

Authors:  Jong-Hyun Kim; Hae-Jin Sohn; Jinyoung Lee; Hee-Jong Yang; Yong-Joon Chwae; Kyongmin Kim; Sun Park; Ho-Joon Shin
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

8.  Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Authors:  Jong-Hyun Kim; Suk-Yul Jung; Yang-Jin Lee; Kyoung-Ju Song; Daeho Kwon; Kyongmin Kim; Sun Park; Kyung-Il Im; Ho-Joon Shin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

9.  Characterization and biological activity against Naegleria fowleri of amoebicins produced by Bacillus licheniformis D-13.

Authors:  A Gálvez; M Maqueda; P Cordovilla; M Martínez-Bueno; M Lebbadi; E Valdivia
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.